| 来源类型 | Publication |
| Temporal Trends in Anti-Diabetes Drug Use in TRICARE Following Safety Warnings in 2007 About Rosiglitazone | |
| Kate A. Stewart; Brenda M. Natzke; Thomas V. Williams; Elder Granger; S. Ward Casscells; and Thomas W. Croghan | |
| 发表日期 | 2009-11-30 |
| 出版者 | Pharmacoepidemiology and Drug Safety, vol. 18, no. 11 |
| 出版年 | 2009 |
| 语种 | 英语 |
| 概述 | In 2007, highly publicized warnings suggested rosiglitazone, a drug used to treat type 2 diabetes, may be associated with an increased risk of heart attack and cardiovascular-related death. ", |
| 摘要 | In 2007, highly publicized warnings suggested rosiglitazone, a drug used to treat type 2 diabetes, may be associated with an increased risk of heart attack and cardiovascular-related death. This article details the response to these warnings by analyzing anti-diabetes drug use before and after the 2007 warnings in the military health system. We found that the total number of prescriptions for all anti-diabetes medications remained constant before and after the warnings, although prescriptions of rosiglitazone declined by more than 50 percent after the warnings. |
| URL | https://www.mathematica.org/our-publications-and-findings/publications/temporal-trends-in-antidiabetes-drug-use-in-tricare-following-safety-warnings-in-2007-about-rosiglitazone |
| 来源智库 | Mathematica Policy Research (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/486355 |
| 推荐引用方式 GB/T 7714 | Kate A. Stewart,Brenda M. Natzke,Thomas V. Williams,et al. Temporal Trends in Anti-Diabetes Drug Use in TRICARE Following Safety Warnings in 2007 About Rosiglitazone. 2009. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
